Deep search
Profile Picture
  • All
  • Search
  • Images
  • Videos
  • Maps
  • News
  • Copilot
  • More
    • Shopping
    • Flights
    • Travel
  • Notebook
  • Top stories
  • Sports
  • U.S.
  • Local
  • World
  • Science
  • Technology
  • Entertainment
  • Business
  • More
    Politics
Order byBest matchMost fresh
  • Any time
    • Past hour
    • Past 24 hours
    • Past 7 days
    • Past 30 days

News

Figma’s IPO seeks a $13 billion valuation

Digest more
 · 2d · on MSN
Figma aims at $16.4 billion valuation as tech IPOs bounce back
Figma is targeting a fully-diluted valuation of up to $16.4 billion in its initial public offering, as the cloud-based design software firm prepares for a debut on the NYSE that could inject fresh momentum into a resurgent market for tech listings.

Continue reading

Hoodline · 1d
Figma Eyes Up to $16.4 Billion Valuation with NYSE IPO Debut, Raising Over $1 Billion Amidst Tech Sector's IPO Resurgence
 · 1d · on MSN
Figma IPO launch: Stock aims for $16.4 Billion valuation in NYSE debut, signals tech listing comeback
2don MSN
Figma sets price range for NYSE IPO
Design software company Figma is planning to offer about 12.47M class A common shares priced in the range of $25 to $28 per ...
Blockonomi
1d
Figma Reveals $70M Bitcoin ETF Stake Ahead of IPO, Adds Blockchain Stock Option
Figma disclosed a $70M Bitcoin ETF position and blockchain stock plans in its IPO filing, signaling crypto adoption.
1d
How to buy Figma IPO?
Do you want to buy the new Figma IPO shares? Follow the guide to know how and when of the process and how you can be a part of it.
NBC Bay Area22d
Figma files for IPO on NYSE, plans to ‘take big swings’ with ...
Figma filed its IPO prospectus on Tuesday and plans to debut on the NYSE under ticker symbol FIG. The design software vendor said in April that it had confidentially filed for its IPO.

Some results have been hidden because they may be inaccessible to you

Show inaccessible results
Feedback
© 2025 Microsoft
  • Privacy and Cookies
  • Legal
  • Advertise
  • About our ads
  • Help
  • Feedback
  • Your Privacy Choices
  • Consumer Health Privacy